Microbiome-Friend or Foe of Pancreatic Cancer?

immunotherapy inflammation microbiome pancreatic cancer

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 10 10 2021
revised: 15 11 2021
accepted: 27 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 11 12 2021
Statut: epublish

Résumé

Pancreatic ductal adenocarcinoma is one of the deadliest human neoplasms. Despite the development of new surgical and adjuvant therapies, the prognosis remains very poor, with the overall survival rate not exceeding 9%. There is now increasing evidence that the human microbiome, which is involved in many physiological functions, including the regulation of metabolic processes and the modulation of the immune system, is possibly linked to pancreatic oncogenesis. However, the exact mechanisms of action are poorly understood. Our review summarizes the current understanding of how the microbiome affects pancreatic cancer development and progression. We discuss potential pathways of microbe translocation to the pancreas, as well as the mechanism of their action. We describe the role of the microbiome as a potential marker of pancreatic cancer diagnosis, progression, and survival. Finally, we discuss the possibilities of modifying the microbiome to improve treatment effectiveness for this deadly disease.

Identifiants

pubmed: 34884327
pii: jcm10235624
doi: 10.3390/jcm10235624
pmc: PMC8658245
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : National Science Center
ID : 2017/27/B/NZ5/02904

Références

Cell. 2019 Aug 8;178(4):795-806.e12
pubmed: 31398337
J Natl Cancer Inst. 2007 Jan 17;99(2):171-5
pubmed: 17228001
Front Microbiol. 2016 Jul 11;7:1081
pubmed: 27462309
Br J Surg. 2021 Jun 22;108(6):709-716
pubmed: 34157083
Pancreas. 2012 Apr;41(3):435-40
pubmed: 22422136
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
Gut. 2013 Dec;62(12):1764-70
pubmed: 22990306
Korean J Hepatol. 2010 Mar;16(1):49-56
pubmed: 20375642
J Clin Invest. 2012 Apr;122(4):1519-28
pubmed: 22406536
Oncotarget. 2017 Jun 29;8(38):63562-63573
pubmed: 28969011
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
Trends Mol Med. 2017 May;23(5):465-481
pubmed: 28400243
Gastrointest Tumors. 2017 Mar;3(3-4):125-127
pubmed: 28611978
Nature. 2019 Oct;574(7777):264-267
pubmed: 31578522
Cancer Discov. 2018 Apr;8(4):403-416
pubmed: 29567829
Drug Discov Today. 2021 Sep;26(9):2198-2203
pubmed: 34329771
Anaerobe. 2017 Oct;47:18-24
pubmed: 28323133
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
J Clin Invest. 2014 Oct;124(10):4212-8
pubmed: 25271726
Dig Liver Dis. 2018 Dec;50(12):1257-1271
pubmed: 30219670
Am J Surg. 1993 Jan;165(1):68-72; discussion 72-3
pubmed: 8380315
Nat Immunol. 2020 Oct;21(10):1152-1159
pubmed: 32807942
Nat Genet. 2020 Mar;52(3):320-330
pubmed: 32025001
Sci Rep. 2019 Nov 14;9(1):16801
pubmed: 31727922
Gut. 2012 Apr;61(4):582-8
pubmed: 21994333
BMC Microbiol. 2019 Feb 18;19(1):42
pubmed: 30777006
Carcinogenesis. 2018 Jul 30;39(8):1068-1078
pubmed: 29846515
Ann Oncol. 2017 May 1;28(5):985-995
pubmed: 28453689
J Clin Periodontol. 1984 Apr;11(4):209-20
pubmed: 6368612
Cancers (Basel). 2020 Sep 18;12(9):
pubmed: 32962112
Trends Cancer. 2019 Nov;5(11):670-676
pubmed: 31735286
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Gut. 2018 Jan;67(1):120-127
pubmed: 27742762
Oncotarget. 2017 Jun 29;8(56):95176-95191
pubmed: 29221120
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Cancer Med. 2021 Aug;10(15):5041-5050
pubmed: 34250759
Clin Microbiol Rev. 2000 Oct;13(4):547-58
pubmed: 11023956
Gastroenterology. 1986 Aug;91(2):433-8
pubmed: 3522342
Ann Oncol. 2012 Nov;23(11):2983-2989
pubmed: 22689178
Gut. 2021 May;70(5):999-1001
pubmed: 32816963
Science. 2020 May 29;368(6494):973-980
pubmed: 32467386
World J Gastroenterol. 2013 Jul 14;19(26):4234-41
pubmed: 23864789
Gut. 2019 Dec;68(12):2186-2194
pubmed: 30872392
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
Small. 2015 Jan 27;11(4):456-61
pubmed: 25196673
World J Gastroenterol. 2010 Jun 21;16(23):2881-8
pubmed: 20556833
Gastroenterology. 2018 Jul;155(1):33-37.e6
pubmed: 29630898
World J Gastroenterol. 2018 May 28;24(20):2137-2151
pubmed: 29853732
Nature. 2020 Mar;579(7800):567-574
pubmed: 32214244
Oncologist. 2020 Jul;25(7):579-584
pubmed: 32181968
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
Oncologist. 2020 Jan;25(1):55-63
pubmed: 31292268
Clin Gastroenterol Hepatol. 2019 Jan;17(2):290-295
pubmed: 30144522
Int J Cancer. 2016 Jan 15;138(2):340-7
pubmed: 26235255
BMC Microbiol. 2008 Dec 18;8:229
pubmed: 19094203
Biology (Basel). 2021 Mar 13;10(3):
pubmed: 33805810
Clin Transl Immunology. 2016 Jul 22;5(7):e92
pubmed: 27525065
Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):575-83
pubmed: 24322741
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
Science. 2017 Sep 15;357(6356):1156-1160
pubmed: 28912244

Auteurs

Jaroslaw Daniluk (J)

Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.

Urszula Daniluk (U)

Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland.

Pawel Rogalski (P)

Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.

Andrzej Dabrowski (A)

Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.

Agnieszka Swidnicka-Siergiejko (A)

Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.

Classifications MeSH